Patents by Inventor Richard D. Conticello

Richard D. Conticello has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7723348
    Abstract: Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs.
    Type: Grant
    Filed: April 24, 2008
    Date of Patent: May 25, 2010
    Assignee: Memory Pharmaceuticals Corporation
    Inventors: Allen Hopper, Robert F. Dunn, Erik Mikal Kuester, Richard D. Conticello
  • Publication number: 20090099175
    Abstract: The present invention if directed to certain cinnoline compounds that are PDE10 inhibitors, pharmaceutical compositions containing such compounds and processes for preparing such compounds. The invention is also directed to methods of treating diseases mediated by PDE10 enzyme, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.
    Type: Application
    Filed: February 28, 2007
    Publication date: April 16, 2009
    Inventors: Mark P. Arrington, Allen T. Hopper, Richard D. Conticello, Truc M. Nguyen, Hans-Jurgen E. Hess, Carla Maria Gauss, Stephen A. Hitchcock
  • Patent number: 7432266
    Abstract: Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs.
    Type: Grant
    Filed: October 14, 2005
    Date of Patent: October 7, 2008
    Assignee: Memory Pharmaceuticals Corporation
    Inventors: Allen Hopper, Robert F. Dunn, Erik Mikal Kuester, Richard D. Conticello
  • Publication number: 20080207660
    Abstract: Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs.
    Type: Application
    Filed: April 24, 2008
    Publication date: August 28, 2008
    Inventors: Allen HOPPER, Robert F. Dunn, Erik Mikal Kuester, Richard D. Conticello
  • Patent number: 7208483
    Abstract: Polymeric delivery agents, delivery agent compounds and compositions comprising them which are useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.
    Type: Grant
    Filed: May 28, 2003
    Date of Patent: April 24, 2007
    Assignee: Emisphere Technologies, Inc.
    Inventors: Sam J. Milstein, Eugene N. Barantsevitch, Nai Fang Wang, Jun Liao, John E. Smart, Richard D. Conticello, Raphael M. Ottenbrite
  • Publication number: 20030232085
    Abstract: Polymeric delivery agents, delivery agent compounds and compositions comprising them which are useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.
    Type: Application
    Filed: May 28, 2003
    Publication date: December 18, 2003
    Applicants: Emisphere Technologies, Inc., Virginia Commonwealth University
    Inventors: Sam J. Milstein, Eugene N. Barantsevitch, Nai Fang Wang, Jun Liao, John E. Smart, Richard D. Conticello, Raphael M. Ottenbrite
  • Patent number: 6627228
    Abstract: Polymeric delivery agents, delivery agent compounds and compositions comprising them which are useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.
    Type: Grant
    Filed: October 9, 2001
    Date of Patent: September 30, 2003
    Assignee: Emisphere Technologies, Inc.
    Inventors: Sam J. Milstein, Eugene N. Barantsevitch, Nai Fang Wang, Jun Liao, John E. Smart, Richard D. Conticello, Raphael M. Ottenbrite